The bitter truth about new Covid-19 treatments

Loading player...
The news about dexamethasone – a potential new Covid-19 treatment – is great, but it doesn’t mean we’re out of the woods. Not by a long shot. While it’s natural for us to be enthusiastic about any positive Covid-19 news, whether it’s a new treatment option or a possible vaccine, we also need to be realistic about the ongoing need to slow the spread of the virus. As South Africa reopens amid a rapidly accelerating outbreak, it’s more important than ever that people do everything they can to flatten the curve. And a big part of that is accepting that we’re going to be living with Covid-19 for a long time to come. In this episode, featuring content from the Bloomberg Businessweek podcast, we look at the state of the fight against Covid-19, new treatments, testing, and the reality of the new normal. Learn more about your ad choices. Visit megaphone.fm/adchoices
21 Jun 2020 12PM English South Africa Investing · Business News

Other recent episodes

BN Daybreak Thurs 15 Jan: Abedian on SA Silence about “21st Century Nazis”; Mining Indaba's back story; Sasol Surges

In this morning's briefing, Alec Hogg unpacks a volatile geopolitical landscape where conflicting reports emerge from Iran—Donald Trump claims de-escalation while internal memos suggest mass casualties. We speak to Iranian-born and bred entrepreneur and former UCT Economics Prof Iraj Abedian, who delivers a scathing critique of the South African government's…
14 Jan 11PM 17 min

BN Briefing: Leaked Iran death toll, US-SA relations, and Equities vs Gold

In this BizNews Briefing, Dr. Iraj Abedian reveals leaked reports of 12,000 deaths in Iran, questioning the South African government’s silence. The Hudson Institute's Josh Meservey analyses Pretoria’s alignment with American adversaries. Plus, David Shapiro discusses the "survival mode" of South African business, and Peter Major explains why equities historically…
14 Jan 5AM 13 min